Publications by authors named "Nukhet Eliyatkin"
Purpose: To investigate the effects of adalimumab pretreatment on the lipopolysaccharide-mediated myocardial injury.
Methods: Twenty-eight Wistar rats were randomized into four groups (n=7). Control (C) group animals were injected once a day with intraperitoneal (i.
Article Synopsis
- * An analysis of ten patients treated between 2000 and 2013 at a specific hospital showed a mean age of 59.7 years, with various surgical treatments resulting in a disease-free survival rate of 52.5% and an overall survival rate of 53.3%.
- * The findings suggest that while the prognosis for carcinosarcomas is typically poor, the survival rates in this study didn't differ significantly from those of common epithelial tumors, indicating a need for more extensive research.
Article Synopsis
- - The study analyzed 633 breast cancer patients, comparing the clinical features and metastatic behaviors of three types: invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and mixed ductal/lobular carcinoma (MDLC).
- - Results indicated that MDLC is generally diagnosed at a more advanced stage and has unique tumor characteristics, but the overall survival rates for MDLC did not significantly differ from those for IDC and ILC.
- - Key differences were found in tumor size, staging at diagnosis, HER2 expression, and the presence of bone metastases among the different cancer types, indicating varied prognostic factors.
Aims: The primary objective of this study was to clarify the influence of histotype on the outcome of D1/D2 gastrectomized patients with pathologically proven R0 resection. The secondary objective was to demonstrate overall survival (OS), disease-free survival (DFS), and locoregional recurrence rates following standard curative surgery.
Patients And Methods: All patients had either pure signet-ring cell carcinoma (SRCC)/poorly differentiated adenocarcinoma (PDC) or moderately differentiated adenocarcinoma (MDC) of the stomach, preoperative radiologic evidence of locoregional disease, and no history of neoadjuvant therapy.
The patient, who was being followed up for Mantle Cell Lymphoma, was diagnosed with Mast Cell Leukemia 2 years after receiving R-CHOP treatment. The results of flow cytometry, which was performed upon determining leucocytosis and detecting blasts in the peripheral smear following the patient's presentation due to his poor general condition, was consistent with Mantle Cell Leukemia. This case is being presented since there are a very limited number of previously published cases on this topic.
View Article and Find Full Text PDF